Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03191786
Title A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy (IPSOS)
Acronym IPSOS
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Age Groups: adult | senior
Covered Countries ITA | GBR | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST